Showing results (1821-1830 of 1,948) with videos related to

Sort By:
Pageof 195
Medical Oncology (Northwood, London, England)|December 17, 2013
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancerYa-Qiang Huang, Zhao-Dong Han, Yu-Xiang Liang, et al.
Cancer Research|November 26, 2020
Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver CancerSeong Hwi Hong, Keun Hong Son, Sang Yun Ha, et al.
JHEP Reports : Innovation in Hepatology|March 17, 2022
Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis BNicholas van Buuren, Ricardo Ramirez, Cameron Soulette, et al.
IEEE Transactions on Bio-Medical Engineering|March 11, 2022
Optimized Signal Quality Assessment for Photoplethysmogram Signals Using Feature SelectionFahimeh Mohagheghian, Dong Han, Andrew Peitzsch, et al.
Acta Pharmacologica Sinica|January 27, 2015
The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthmaJing Xu, Yan-ting Zhu, Gui-zuo Wang, et al.
JMIR Cardio|November 28, 2023
Accuracy, Usability, and Adherence of Smartwatches for Atrial Fibrillation Detection in Older Adults After Stroke: Randomized Controlled TrialEric Y Ding, Khanh-Van Tran, Darleen Lessard, et al.
Cancer Research|April 29, 2014
API5 confers tumoral immune escape through FGF2-dependent cell survival pathwayKyung Hee Noh, Seok-Ho Kim, Jin Hee Kim, et al.
Journal of Biomedical Nanotechnology|September 11, 2013
In vivo delivery of Atoh1 gene to rat cochlea using a dendrimer-based nanocarrierNan Wu, Min Li, Zhi-Ting Chen, et al.
Clinics and Research in Hepatology and Gastroenterology|April 16, 2023
Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trialDan-Ni Liu, Qiu-Yan Wang, Pei-Yuan Li, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial reportWen-Ying Zhang, Yao Wang, Ye-Lei Guo, et al.
Pageof 195